Macquarie Group’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $136M | Sell |
1,315,859
-6,925
| -0.5% | -$618K | 0.59% | 29 |
|
|
2026
Q1 | $95M | Sell |
1,322,784
-32,593
| -2% | -$2.51M | 0.57% | 36 |
|
|
2025
Q4 | $108M | Sell |
1,355,377
-152,691
| -10% | -$12M | 0.47% | 43 |
|
|
2025
Q3 | $114M | Sell |
1,508,068
-68,823
| -4% | -$4.72M | 0.13% | 190 |
|
|
2025
Q2 | $109M | Buy |
1,576,891
+13,820
| +0.9% | +$906K | 0.13% | 207 |
|
|
2025
Q1 | $106M | Sell |
1,563,071
-3,284,426
| -68% | -$197M | 0.13% | 217 |
|
|
2024
Q4 | $215M | Buy |
4,847,497
+147,009
| +3% | +$8.25M | 0.26% | 79 |
|
|
2024
Q3 | $296M | Sell |
4,700,488
-521,881
| -10% | -$30.4M | 0.32% | 48 |
|
|
2024
Q2 | $308M | Sell |
5,222,369
-138,007
| -3% | -$8.63M | 0.35% | 47 |
|
|
2024
Q1 | $428M | Sell |
5,360,376
-278,750
| -5% | -$21.3M | 0.48% | 22 |
|
|
2023
Q4 | $445M | Sell |
5,639,126
-691,191
| -11% | -$49.2M | 0.51% | 20 |
|
|
2023
Q3 | $442M | Sell |
6,330,317
-190,378
| -3% | -$13.5M | 0.56% | 22 |
|
|
2023
Q2 | $451M | Buy |
6,520,695
+575,035
| +10% | +$40.9M | 0.52% | 34 |
|
|
2023
Q1 | $442M | Buy |
5,945,660
+85,942
| +1% | +$7.21M | 0.52% | 40 |
|
|
2022
Q4 | $546M | Sell |
5,859,718
-285,195
| -5% | -$27.5M | 0.64% | 16 |
|
|
2022
Q3 | $586M | Sell |
6,144,913
-237,833
| -4% | -$23.5M | 0.72% | 11 |
|
|
2022
Q2 | $591M | Sell |
6,382,746
-150,759
| -2% | -$14.7M | 0.66% | 14 |
|
|
2022
Q1 | $661M | Sell |
6,533,505
-701,393
| -10% | -$73.7M | 0.5% | 21 |
|
|
2021
Q4 | $746M | Sell |
7,234,898
-1,605,090
| -18% | -$148M | 0.62% | 13 |
|
|
2021
Q3 | $750M | Sell |
8,839,988
-739,663
| -8% | -$62M | 0.64% | 13 |
|
|
2021
Q2 | $799M | Buy |
9,579,651
+56,454
| +0.6% | +$4.62M | 0.66% | 15 |
|
|
2021
Q1 | $716M | Sell |
9,523,197
-437,909
| -4% | -$31.9M | 1.01% | 18 |
|
|
2020
Q4 | $680M | Sell |
9,961,106
-615,150
| -6% | -$40M | 0.99% | 22 |
|
|
2020
Q3 | $618M | Sell |
10,576,256
-233,313
| -2% | -$14.5M | 1.05% | 25 |
|
|
2020
Q2 | $702M | Sell |
10,809,569
-970,586
| -8% | -$61.1M | 1.21% | 13 |
|
|
2020
Q1 | $699M | Sell |
11,780,155
-1,274,549
| -10% | -$85.1M | 1.44% | 7 |
|
|
2019
Q4 | $970M | Sell |
13,054,704
-247,389
| -2% | -$17.4M | 1.38% | 9 |
|
|
2019
Q3 | $839M | Sell |
13,302,093
-603,347
| -4% | -$35.8M | 1.41% | 10 |
|
|
2019
Q2 | $758M | Buy |
13,905,440
+1,372,275
| +11% | +$73.9M | 1.28% | 20 |
|
|
2019
Q1 | $676M | Buy |
12,533,165
+2,483,839
| +25% | +$153M | 1.15% | 32 |
|
|
2018
Q4 | $658M | Sell |
10,049,326
-67,093
| -0.7% | -$5.01M | 1.27% | 19 |
|
|
2018
Q3 | $796M | Sell |
10,116,419
-184,190
| -2% | -$13.2M | 1.3% | 9 |
|
|
2018
Q2 | $663M | Buy |
10,300,609
+403,170
| +4% | +$26.6M | 1.14% | 29 |
|
|
2018
Q1 | $616M | Buy |
9,897,439
+678,074
| +7% | +$48.7M | 1.12% | 32 |
|
|
2017
Q4 | $669M | Buy |
9,219,365
+414,086
| +5% | +$30.1M | 1.18% | 28 |
|
|
2017
Q3 | $716M | Sell |
8,805,279
-898,122
| -9% | -$71M | 1.28% | 21 |
|
|
2017
Q2 | $781M | Sell |
9,703,401
-48,860
| -0.5% | -$3.86M | 1.43% | 14 |
|
|
2017
Q1 | $766M | Buy |
9,752,261
+225,981
| +2% | +$18M | 1.39% | 23 |
|
|
2016
Q4 | $752M | Buy |
9,526,280
+1,359,100
| +17% | +$110M | 1.44% | 22 |
|
|
2016
Q3 | $727M | Buy |
8,167,180
+459,657
| +6% | +$43.4M | 1.4% | 21 |
|
|
2016
Q2 | $738M | Buy |
7,707,523
+682,784
| +10% | +$68M | 1.45% | 14 |
|
|
2016
Q1 | $729M | Buy |
7,024,739
+155,826
| +2% | +$15.2M | 1.47% | 2 |
|
|
2015
Q4 | $672M | Buy |
6,868,913
+377,771
| +6% | +$37M | 1.38% | 3 |
|
|
2015
Q3 | $626M | Sell |
6,491,142
-105,965
| -2% | -$11.1M | 1.34% | 6 |
|
|
2015
Q2 | $692M | Buy |
6,597,107
+34,116
| +0.5% | +$3.49M | 1.37% | 1 |
|
|
2015
Q1 | $677M | Sell |
6,562,991
-176,904
| -3% | -$17.9M | 1.33% | 2 |
|
|
2014
Q4 | $649M | Sell |
6,739,895
-206,173
| -3% | -$18.2M | 1.34% | 1 |
|
|
2014
Q3 | $553M | Buy |
6,946,068
+294,580
| +4% | +$23.2M | 1.19% | 2 |
|
|
2014
Q2 | $501M | Sell |
6,651,488
-40,334
| -0.6% | -$3.05M | 1.12% | 4 |
|
|
2014
Q1 | $501M | Sell |
6,691,822
-80,714
| -1% | -$5.7M | 0.87% | 20 |
|
|
2013
Q4 | $485M | Buy |
6,772,536
+142,577
| +2% | +$9.16M | 0.87% | 22 |
|
|
2013
Q3 | $376M | Buy |
6,629,959
+376,177
| +6% | +$22.4M | 0.74% | 27 |
|
|
2013
Q2 | $358M | Buy |
+6,253,782
| New | +$362M | 0.78% | 26 |
|
Other funds holding CVS
Macquarie Group's CVS Position: Q2 2026 in Review
Macquarie Group reduced its CVS Health (CVS) stake by 0.52% in Q2 2026, selling an estimated $618K and leaving 1,315,859 shares worth $136M. The position accounts for 0.59% of the portfolio, ranked #29.
Macquarie Group first reported a position in CVS in Q2 2013 and has held it in 53 quarters since. The position peaked at $970M in Q4 2019. 2,064 funds tracked by Wall St. Rank hold CVS as of Q2 2026.
- Macquarie Group held 1,315,859 shares of CVS Health worth $136M as of Q2 2026.
- Macquarie Group sold 6,925 CVS Health shares in Q2 2026, an estimated $618K.
- CVS Health made up 0.59% of Macquarie Group's portfolio in Q2 2026, its #29 holding.
- Macquarie Group first reported a position in CVS Health in Q2 2013 and has held it in 53 quarters since.
- Macquarie Group's CVS Health position peaked at $970M in Q4 2019.
- 2,064 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.
Based on Macquarie Group's 13F filing for Q2 2026, filed 14 Aug 2026.